| __timestamp | Amphastar Pharmaceuticals, Inc. | Exelixis, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 51256000 | 23068000 |
| Thursday, January 1, 2015 | 77347000 | 33277000 |
| Friday, January 1, 2016 | 104189000 | 184902000 |
| Sunday, January 1, 2017 | 90795000 | 437411000 |
| Monday, January 1, 2018 | 106985000 | 827478000 |
| Tuesday, January 1, 2019 | 131923000 | 934678000 |
| Wednesday, January 1, 2020 | 143340000 | 951266000 |
| Friday, January 1, 2021 | 199739000 | 1382097000 |
| Saturday, January 1, 2022 | 248860000 | 1553153000 |
| Sunday, January 1, 2023 | 351121000 | 1757661000 |
| Monday, January 1, 2024 | 2168701000 |
Infusing magic into the data realm
In the competitive world of biotechnology, financial performance is a key indicator of a company's success. Over the past decade, Exelixis, Inc. and Amphastar Pharmaceuticals, Inc. have shown distinct trajectories in their gross profit margins. Starting in 2014, Amphastar's gross profit was approximately double that of Exelixis. However, by 2023, Exelixis had surged ahead, boasting a gross profit nearly five times that of Amphastar.
This data highlights the dynamic nature of the biotech industry, where strategic decisions and market conditions can lead to significant financial shifts.
Who Generates Higher Gross Profit? Johnson & Johnson or Exelixis, Inc.
Who Generates Higher Gross Profit? Pfizer Inc. or Exelixis, Inc.
Gross Profit Comparison: Amgen Inc. and Exelixis, Inc. Trends
Vertex Pharmaceuticals Incorporated and Exelixis, Inc.: A Detailed Gross Profit Analysis
Regeneron Pharmaceuticals, Inc. vs Exelixis, Inc.: A Gross Profit Performance Breakdown
Gross Profit Comparison: BioMarin Pharmaceutical Inc. and Exelixis, Inc. Trends
Gross Profit Trends Compared: Walgreens Boots Alliance, Inc. vs Exelixis, Inc.
Gross Profit Analysis: Comparing Exelixis, Inc. and Lantheus Holdings, Inc.
Exelixis, Inc. vs Amneal Pharmaceuticals, Inc.: A Gross Profit Performance Breakdown
Gross Profit Analysis: Comparing Exelixis, Inc. and HUTCHMED (China) Limited
Exelixis, Inc. and Ligand Pharmaceuticals Incorporated: A Detailed Gross Profit Analysis
Gross Profit Trends Compared: Vericel Corporation vs Amphastar Pharmaceuticals, Inc.